Olfactory Dysfunction in the Elderly: Basic Circuitry and Alterations with Normal Aging and Alzheimer's Disease

Current Translational Geriatrics and Gerontology Reports

Volumn 3, Issue 2, 2014, Pages 91-100

  Masurkar, Arjun V ^c,d   Devanand, D P ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c Neurological Institute of New York ^*  (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid plaque; Early detection; Entorhinal cortex; Hippocampus; Mild cognitive impairment; Neurofibrillary tangle; Olfaction; Olfactory bulb; Olfactory epithelium; Orbitofrontal cortex; Piriform cortex; Tau

Indexed keywords

ALZHEIMER DISEASE; BEHAVIOR CHANGE; ELDERLY CARE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLFACTORY BULB; OLFACTORY DISCRIMINATION; OLFACTORY NERVE DISEASE; OLFACTORY SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYRIFORM CORTEX; REVIEW; SPATIAL MEMORY; WORKING MEMORY;

EID: 84935000313     PISSN: 16726340     EISSN: 21624941     Source Type: Journal    
DOI: 10.1007/s13670-014-0080-y     Document Type: Review

References (102)

1. Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8: 329-39.
2. Shepherd GM, et al. Olfactory Bulb. In: Shepherd GM, editors. Synaptic Organization of the Brain. Oxford, New York, 2004. pp. 165-216.
3. Doty RL. Office procedures for quantitative assessment of olfactory function. Am J Rhinol. 2007;21: 460-73.
4. Paik SI, Lehman MN, Seiden AM, Duncan HJ, Smith DV. Human olfactory biopsy. The influence of age and receptor distribution. Arch Otolaryngol Head Neck Surg. 1992;118: 731-8.
5. Rawson NE, Gomez G, Cowart BJ, Kriete A, Pribitkin E, Restrepo D. Age-associated loss of selectivity in human olfactory sensory neurons. Neurobiol Aging. 2012;33: 1913-9.
6. Maresh A, Rodriguez Gil D, Whitman MC, Greer CA. Principles of glomerular organization in the human olfactory bulb-implications for odor processing. PLoS One. 2008;3: e2640.
7. Meisami E, Mikhail L, Baim D, Bhatnagar KP. Human olfactory bulb: aging of glomeruli and mitral cells and a search for the accessory olfactory bulb. Ann N Y Acad Sci. 1998;855: 708-15.
8. Morgan CD, Geisler MW, Covington JW, Polich J, Murphy C. Olfactory P3 in young and older adults. Psychophysiology. 1999;36: 281-7.
9. Yousem DM, Maldjian JA, Hummel T, Alsop DC, Geckle RJ, Kraut MA, et al. The effect of age on odor-stimulated functional MR imaging. AJNR Am J Neuroradiol. 1999;20: 600-8.
10. Suzuki Y, Critchley HD, Suckling J, Fukuda R, Williams SC, Andrew C, et al. Functional magnetic resonance imaging of odor identification: the effect of aging. J Gerontol A Biol Sci Med Sci. 2001;56: M756-760.
11. Kareken DA, Mosnik DM, Doty RL, Dzemidzic M, Hutchins GD. Functional anatomy of human odor sensation, discrimination, and identification in health and aging. Neuropsychology. 2003;17: 482-95.
12. Cerf-Ducastel B, Murphy C. FMRI brain activation in response to odors is reduced in primary olfactory areas of elderly subjects. Brain Res. 2003;986: 39-53.
13. Wang J, Eslinger PJ, Smith MB, Yang QX. Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci. 2005;60: 510-4.
14. Mann DM, Tucker CM, Yates PO. Alzheimer's disease: an olfactory connection? Mech Ageing Dev. 1988;42: 1-15.
15. Reyes PF, Deems DA, Suarez MG. Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study. Brain Res Bull. 1993;32: 1-5.
16. ter Laak HJ, Renkawek K, van Workum FP. The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer Dis Assoc Disord. 1994;8: 38-48.
17. Mundinano IC, Caballero MC, Ordonez C, Hernandez M, DiCaudo C, Marcilla I, et al. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol. 2011;122: 61-74.
18. Cai Y, Xue ZQ, Zhang XM, Li MB, Wang H, Luo XG, et al. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation. Neuroscience. 2012;215: 160-73.
19. Esiri MM, Wilcock GK. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1984;47: 56-60.
20. Ohm TG, Braak H. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol. 1987;73: 365-9.
21. Loopuijt LD, Sebens JB. Loss of dopamine receptors in the olfactory bulb of patients with Alzheimer's disease. Brain Res. 1990;529: 239-44.
22. Hyman BT, Arriagada PV, van Hoesen GW. Pathologic changes in the olfactory system in aging and Alzheimer's disease. Ann N Y Acad Sci. 1991;640: 14-9.
23. Struble RG, Clark HB. Olfactory bulb lesions in Alzheimer's disease. Neurobiol Aging. 1992;13: 469-73.
24. Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J Alzheimers Dis. 2005;7: 149-57. discussion 173-180.
25. Kovacs T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport. 2001;12: 285-8.
26. Kovacs T, Cairns NJ, Lantos PL. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol. 1999;25: 481-91.
27. Li W, Howard JD, Gottfried JA. Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease. Brain. 2010;133: 2714-26.
28. Wang J, Eslinger PJ, Doty RL, Zimmerman EK, Grunfeld R, Sun X, et al. Olfactory deficit detected by fMRI in early Alzheimer's disease. Brain Res. 2010;1357: 184-94.
29. Kareken DA, Doty RL, Moberg PJ, Mosnik D, Chen SH, Farlow MR, et al. Olfactory-evoked regional cerebral blood flow in Alzheimer's disease. Neuropsychology. 2001;15: 18-29.
30. Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, et al. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. Arch Gen Psychiatry. 1991;48: 840-7.
31. Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C, et al. Functional representation of olfactory impairment in early Alzheimer's disease. J Alzheimers Dis. 2010;22: 581-91.
32. Meisami E. A proposed relationship between increases in the number of olfactory receptor neurons, convergence ratio and sensitivity in the developing rat. Brain Res Dev Brain Res. 1989;46: 9-19.
33. Hinds JW, McNelly NA. Aging in the rat olfactory system: correlation of changes in the olfactory epithelium and olfactory bulb. J Comp Neurol. 1981;203: 441-53.
34. Lee AC, Tian H, Grosmaitre X, Ma M. Expression patterns of odorant receptors and response properties of olfactory sensory neurons in aged mice. Chem Senses. 2009;34: 695-703.
35. Richard MB, Taylor SR, Greer CA. Age-induced disruption of selective olfactory bulb synaptic circuits. Proc Natl Acad Sci U S A. 2010;107: 15613-8.
36. Mirich JM, Williams NC, Berlau DJ, Brunjes PC. Comparative study of aging in the mouse olfactory bulb. J Comp Neurol. 2002;454: 361-72.
37. Tropepe V, Craig CG, Morshead CM, van der Kooy D. Transforming growth factor-alpha null and senescent mice show decreased neural progenitor cell proliferation in the forebrain subependyma. J Neurosci. 1997;17: 7850-9.
38. Enwere E, Shingo T, Gregg C, Fujikawa H, Ohta S, Weiss S. Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination. J Neurosci. 2004;24: 8354-65.
39. Mobley AS, Bryant AK, Richard MB, Brann JH, Firestein SJ, Greer CA. Age-dependent regional changes in the rostral migratory stream. Neurobiol Aging. 2013;34: 1873-81.
40. Hinds JW, McNelly NA. Aging in the rat olfactory bulb: quantitative changes in mitral cell organelles and somato-dendritic synapses. J Comp Neurol. 1979;184: 811-20.
41. Forbes WB. Aging-related morphological changes in the main olfactory bulb of the Fischer 344 rat. Neurobiol Aging. 1984;5: 93-9.
42. Gocel J, Larson J. Evidence for loss of synaptic AMPA receptors in anterior piriform cortex of aged mice. Front Aging Neurosci. 2013;5: 39.
43. Samson RD, Barnes CA. Impact of aging brain circuits on cognition. Eur J Neurosci. 2013;37: 1903-15.
44. Terranova JP, Perio A, Worms P, Le Fur G, Soubrie P. Social olfactory recognition in rodents: deterioration with age, cerebral ischaemia and septal lesion. Behav Pharmacol. 1994;5: 90-8.
45. Schoenbaum G, Setlow B, Saddoris MP, Gallagher M. Encoding changes in orbitofrontal cortex in reversal-impaired aged rats. J Neurophysiol. 2006;95: 1509-17.
46. Guerin D, Sacquet J, Mandairon N, Jourdan F, Didier A. Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice. Neurobiol Aging. 2009;30: 272-83.
47. Kameshima N, Nanjou T, Fukuhara T, Yanagisawa D, Tooyama I. Correlation of Abeta deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease. Neurosci Lett. 2012;513: 166-9.
48. Wu N, Rao X, Gao Y, Wang J, Xu F. Amyloid-beta deposition and olfactory dysfunction in an Alzheimer's disease model. J Alzheimers Dis. 2013;37: 699-712.
49. Cheng N, Cai H, Belluscio L. In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function. J Neurosci. 2011;31: 13699-704.
50. Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, et al. Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun. 2012;3: 1009. By using a mouse model in which human APP is expressed only in olfactory receptor neurons, the authors demonstrate disruption of the peripheral olfactory circuits in the absence of Aβ plaque.
51. Cheng N, Bai L, Steuer E, Belluscio L. Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer's disease model. J Neurosci. 2013;33: 12208-17.
52. Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta (1-42). J Neurosci Res. 2001;66: 573-82.
53. Lehman EJ, Kulnane LS, Lamb BT. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobiol Aging. 2003;24: 645-53.
54. Cassano T, Romano A, Macheda T, Colangeli R, Cimmino CS, Petrella A, et al. Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res. 2011;224: 408-12. Most animal models of Alzheimer's disease utilize amyloidogenic genes. Here, odor-based memory testing was performed in a transgenic mouse expressing both Aβ and tau pathology. Severe deficits were found, but pathology was limited to higher order olfactory centers and not the olfactory bulb.
55. Wesson DW, Levy E, Nixon RA, Wilson DA. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model. J Neurosci. 2010;30: 505-14.
56. Saiz-Sanchez D, De La Rosa-Prieto C, Ubeda-Banon I, Martinez-Marcos A. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease. Anat Rec (Hoboken). 2013;296: 1413-23.
57. Haughey NJ, Liu D, Nath A, Borchard AC, Mattson MP. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromol Med. 2002;1: 125-35.
58. Demars M, Hu YS, Gadadhar A, Lazarov O. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J Neurosci Res. 2010;88: 2103-17.
59. Sotthibundhu A, Li QX, Thangnipon W, Coulson EJ. Abeta(1-42) stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor. Neurobiol Aging. 2009;30: 1975-85.
60. Zhang C, McNeil E, Dressler L, Siman R. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp Neurol. 2007;204: 77-87.
61. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293: 1487-91.
62. Kim TK, Lee JE, Park SK, Lee KW, Seo JS, Im JY, et al. Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease. Exp Mol Med. 2012;44: 492-502.
63. Saiz-Sanchez D, Ubeda-Banon I, De la Rosa-Prieto C, Martinez-Marcos A. Differential expression of interneuron populations and correlation with amyloid-beta deposition in the olfactory cortex of an AbetaPP/PS1 transgenic mouse model of Alzheimer's disease. J Alzheimers Dis. 2012;31: 113-29.
64. Wesson DW, Borkowski AH, Landreth GE, Nixon RA, Levy E, Wilson DA. Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's beta-amyloidosis mouse model. J Neurosci. 2011;31: 15962-71. The investigators used the Tg2576 Alzheimer mouse to demonstrate that aberrant electrical activity in the OB coincides with amyloid in that region, but prior to the behavioral deficits that coincide with piriform cortex dysfunction.
65. Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, et al. Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. J Alzheimers Dis. 2013;33: 781-96.
66. Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci. 2005;26: 156-60.
67. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2008;29: 693-706.
68. Laakso MP, Tervo S, Hanninen T, Vanhanen M, Hallikainen M, Soininen H. Olfactory identification in non-demented elderly population and in mild cognitive impairment: a comparison of performance in clinical odor identification versus Boston Naming Test. J Neural Transm. 2009;116: 891-5.
69. Bahar-Fuchs A, Chetelat G, Villemagne VL, Moss S, Pike K, Masters CL, et al. Olfactory deficits and amyloid-beta burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis. 2010;22: 1081-7.
70. Velayudhan L, Pritchard M, Powell JF, Proitsi P, Lovestone S. Smell identification function as a severity and progression marker in Alzheimer's disease. Int Psychogeriatr. 2013;25: 1157-66. This group investigated whether olfactory decline correlated with cognitive progression and illness severity in AD patients. AD patients with recent rapid cognitive progression were found to be associated with rapid olfactory decline at 3 months follow-up, whereas non-rapid cognitive progression was associated with slow olfactory decline. Rapid olfactory decline with higher olfactory dysfunction correlated with high illness severity.
71. Westervelt HJ, Bruce JM, Coon WG, Tremont G. Odor identification in mild cognitive impairment subtypes. J Clin Exp Neuropsychol. 2008;30: 151-6.
72. Lehrner J, Pusswald G, Gleiss A, Auff E, Dal-Bianco P. Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment. Clin Neuropsychol. 2009;23: 818-30.
73. Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, et al. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging. 2010;31: 1593-600.
74. Bacon AW, Bondi MW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci. 1998;855: 723-31.
75. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology. 1999;53: 1480-7.
76. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 2000;157: 1399-405.
77. Royall DR, Chiodo LK, Polk MS, Jaramillo CJ. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology. 2002;21: 68-73.
78. Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol. 2005;58: 155-60.
79. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007;78: 30-5.
80. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry. 2008;64: 871-9.
81. Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc. 2008;56: 1517-21.
82. Conti MZ, Vicini-Chilovi B, Riva M, Zanetti M, Liberini P, Padovani A, et al. Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. Arch Clin Neuropsychol. 2013;28: 391-9. This article assessed whether baseline olfactory deficit in MCI patients predicted conversion to dementia. At two years followup, 47 % of dysosmic MCI patients converted to dementia compared to 11 % of the normosmics, with an odds ratio for conversion of 5. 1, independent of baseline MMSE.
83. Murphy C, Jernigan TL, Fennema-Notestine C. Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. J Int Neuropsychol Soc. 2003;9: 459-71.
84. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226: 1441-3.
85. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007;64: 802-8.
86. Bacon Moore AS, Paulsen JS, Murphy C. A test of odor fluency in patients with Alzheimer's and Huntington's disease. J Clin Exp Neuropsychol. 1999;21: 341-51.
87. Kraemer S, Apfelbach R. Olfactory sensitivity, learning and cognition in young adult and aged male Wistar rats. Physiol Behav. 2004;81: 435-42.
88. Patel RC, Larson J. Impaired olfactory discrimination learning and decreased olfactory sensitivity in aged C57Bl/6 mice. Neurobiol Aging. 2009;30: 829-37.
89. LaSarge CL, Montgomery KS, Tucker C, Slaton GS, Griffith WH, Setlow B, et al. Deficits across multiple cognitive domains in a subset of aged Fischer 344 rats. Neurobiol Aging. 2007;28: 928-36.
90. Prediger RD, De-Mello N, Takahashi RN. Pilocarpine improves olfactory discrimination and social recognition memory deficits in 24 month-old rats. Eur J Pharmacol. 2006;531: 176-82.
91. Luu TT, Pirogovsky E, Gilbert PE. Age-related changes in contextual associative learning. Neurobiol Learn Mem. 2008;89: 81-5.
92. Guan X, Dluzen DE. Age related changes of social memory/recognition in male Fischer 344 rats. Behav Brain Res. 1994;61: 87-90.
93. Roman FS, Alescio-Lautier B, Soumireu-Mourat B. Age-related learning and memory deficits in odor-reward association in rats. Neurobiol Aging. 1996;17: 31-40.
94. Phillips M, Boman E, Osterman H, Willhite D, Laska M. Olfactory and visuospatial learning and memory performance in two strains of Alzheimer's disease model mice-a longitudinal study. PLoS One. 2011;6: e19567.
95. Montgomery KS, Simmons RK, Edwards 3rd G, Nicolle MM, Gluck MA, Myers CE, et al. Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research. Neurobiol Aging. 2011;32: 1273-85.
96. Young JW, Sharkey J, Finlayson K. Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment. Neurobiol Aging. 2009;30: 1430-43.
97. Deacon RM, Koros E, Bornemann KD, Rawlins JN. Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behav Brain Res. 2009;197: 466-8.
98. Rey NL, Jardanhazi-Kurutz D, Terwel D, Kummer MP, Jourdan F, Didier A, et al. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. Neurobiol Aging. 2012;33(426): e421-411.
99. Murphy C, Bacon AW, Bondi MW, Salmon DP. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci. 1998;855: 744-50.
100. Olofsson JK, Nordin S, Wiens S, Hedner M, Nilsson LG, Larsson M. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol Aging. 2010;31: 567-77.
101. Doty RL, Petersen I, Mensah N, Christensen K. Genetic and environmental influences on odor identification ability in the very old. Psychol Aging. 2011;26: 864-71.
102. Nee LE, Lippa CF. Inherited Alzheimer's disease PS-1 olfactory function: a 10-year follow-up study. Am J Alzheimers Dis Other Demen. 2001;16: 83-4.